Literature DB >> 17053476

Serum cystatin C as a marker of glomerular filtration rate.

Magdalena Madero1, Mark J Sarnak, Lesley A Stevens.   

Abstract

PURPOSE OF REVIEW: Glomerular filtration rate is widely accepted as the best overall measure of kidney function. Currently available methods to estimate glomerular filtration rate have strengths and limitations. Cystatin C is a novel endogenous filtration marker being considered as a potential replacement for serum creatinine. This review summarizes the currently available glomerular filtration rate estimating equations based on cystatin C and the literature comparing cystatin C and creatinine as filtration markers. RECENT
FINDINGS: In most cystatin C estimating equations, inclusion of age and sex did not substantially improve their performance. Equations yield different glomerular filtration rate estimates for the same level of cystatin C. Variation among equations may be due to differences among the assays or populations in the individual studies. Studies comparing cystatin C with creatinine or creatinine-based estimating equations show heterogeneous results, with some showing improved performance and others showing equivalent performance even in similar populations. These heterogeneous results may be due to inappropriate comparisons between equations developed in one population with those developed in another, or to the differences between assays or population characteristics.
SUMMARY: Cystatin C shows promise as an alternative to serum creatinine but several important questions remain before it can be recommended for use in clinical practice.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17053476     DOI: 10.1097/01.mnh.0000247505.71915.05

Source DB:  PubMed          Journal:  Curr Opin Nephrol Hypertens        ISSN: 1062-4821            Impact factor:   2.894


  41 in total

1.  Urinary clusterin, cystatin C, beta2-microglobulin and total protein as markers to detect drug-induced kidney injury.

Authors:  Frank Dieterle; Elias Perentes; André Cordier; Daniel R Roth; Pablo Verdes; Olivier Grenet; Serafino Pantano; Pierre Moulin; Daniel Wahl; Andreas Mahl; Peter End; Frank Staedtler; François Legay; Kevin Carl; David Laurie; Salah-Dine Chibout; Jacky Vonderscher; Gérard Maurer
Journal:  Nat Biotechnol       Date:  2010-05       Impact factor: 54.908

2.  A panel of urinary biomarkers to monitor reversibility of renal injury and a serum marker with improved potential to assess renal function.

Authors:  Josef S Ozer; Frank Dieterle; Sean Troth; Elias Perentes; André Cordier; Pablo Verdes; Frank Staedtler; Andreas Mahl; Olivier Grenet; Daniel R Roth; Daniel Wahl; François Legay; Daniel Holder; Zoltan Erdos; Katerina Vlasakova; Hong Jin; Yan Yu; Nagaraja Muniappa; Tom Forest; Holly K Clouse; Spencer Reynolds; Wendy J Bailey; Douglas T Thudium; Michael J Topper; Thomas R Skopek; Joseph F Sina; Warren E Glaab; Jacky Vonderscher; Gérard Maurer; Salah-Dine Chibout; Frank D Sistare; David L Gerhold
Journal:  Nat Biotechnol       Date:  2010-05       Impact factor: 54.908

Review 3.  Proteomic biomarkers in kidney disease: issues in development and implementation.

Authors:  Harald Mischak; Christian Delles; Antonia Vlahou; Raymond Vanholder
Journal:  Nat Rev Nephrol       Date:  2015-02-03       Impact factor: 28.314

4.  Advances in glomerular filtration rate estimation.

Authors:  Malik A Rabbani
Journal:  Sultan Qaboos Univ Med J       Date:  2014-04-07

5.  Endogenous sex steroid hormones and measures of chronic kidney disease (CKD) in a nationally representative sample of men.

Authors:  Stella Yi; Elizabeth Selvin; Sabine Rohrmann; Shehzad Basaria; Andy Menke; Nader Rifai; Eliseo Guallar; Elizabeth A Platz; Brad Astor
Journal:  Clin Endocrinol (Oxf)       Date:  2008-10-21       Impact factor: 3.478

6.  Metabolic abnormalities are present in adults with elevated serum cystatin C.

Authors:  Paul Muntner; Suma Vupputuri; Josef Coresh; Jaime Uribarri; Caroline S Fox
Journal:  Kidney Int       Date:  2009-03-18       Impact factor: 10.612

7.  Age, gender, and race effects on cystatin C levels in US adolescents.

Authors:  Darcy Groesbeck; Anna Köttgen; Rulan Parekh; Elizabeth Selvin; George J Schwartz; Josef Coresh; Susan Furth
Journal:  Clin J Am Soc Nephrol       Date:  2008-09-24       Impact factor: 8.237

8.  Interruption of antiretroviral therapy is associated with increased plasma cystatin C.

Authors:  Amanda Mocroft; Christina Wyatt; Lynda Szczech; Jacquie Neuhaus; Wafaa El-Sadr; Russell Tracy; Lewis Kuller; Michael Shlipak; Brian Angus; Harting Klinker; Michael Ross
Journal:  AIDS       Date:  2009-01-02       Impact factor: 4.177

9.  Study Protocol--accurate assessment of kidney function in Indigenous Australians: aims and methods of the eGFR study.

Authors:  Louise J Maple-Brown; Paul D Lawton; Jaquelyne T Hughes; Suresh K Sharma; Graham Rd Jones; Andrew G Ellis; Wendy Hoy; Alan Cass; Richard J Macisaac; Ashim K Sinha; Mark Ab Thomas; Leonard S Piers; Leigh C Ward; Katrina Drabsch; Sianna Panagiotopoulos; Robyn McDermott; Kevin Warr; Sajiv Cherian; Alex Brown; George Jerums; Kerin O'Dea
Journal:  BMC Public Health       Date:  2010-02-19       Impact factor: 3.295

10.  Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3,418 individuals with CKD.

Authors:  Lesley A Stevens; Josef Coresh; Christopher H Schmid; Harold I Feldman; Marc Froissart; John Kusek; Jerome Rossert; Frederick Van Lente; Robert D Bruce; Yaping Lucy Zhang; Tom Greene; Andrew S Levey
Journal:  Am J Kidney Dis       Date:  2008-03       Impact factor: 8.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.